Sarepta Therapeutics, INC.

Based in CA

🤖

AI Overview

With $6.3M in lobbying spend across 35 quarterly filings, Sarepta Therapeutics, INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2018 to 2025.

$6.3M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$540K
2019	$930K
2020	$490K
2021	$560K
2022	$630K
2023	$910K
2024	$1.0M
2025	$1.2M

Issues Lobbied

Budget/Appropriations Health Issues Medicare/Medicaid Taxation Science/Technology Pharmacy

Lobbying Firms

Sarepta Therapeutics, INC.

Lobbyists

Diane Berry Stacey Frisk Carolyn Hickey Kip Payne

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation, Science/Technology and 1 more

•S.Con.Res. 25 - Senate Budget Resolution
•H.Res. 553 - House Budget Resolution
•HR 244 - Consolidated Appropriations Act of 2017
•H.J.Res. 123, HR 1370 - Continuing Resolution
•appropriations generally,

•Issues: Innovation, Duchenne muscular dystrophy, platform technologies
•PL 114-255 - 21st Century Cures implementation
•S.204 - Right to Try Act of 2017
•S.771 - Improving Access To Affordable Prescripti

•Medicaid Drug Rebate Program, coverage, state level implementation, waivers
•H.R. 3921 - Healthy Kids Act
•S. 1827 - Kids Act of 2017

•Request support for enforcement of existing law

•Communication regarding education and outreach of company; Communication regarding Newborn Screening Saves Lives Reauthorization Act; Communication regarding guidance on Indications and Usage Section